Maya Merabishvili
Overview
Explore the profile of Maya Merabishvili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1076
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munteanu D, Dunn J, Apjok G, Kintses B, Griselain J, Steurs G, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001358
: Bacteriophages (phages) are viruses that infect and kill bacteria. The antimicrobial resistance crisis has driven renewed interest in phage therapy, including the use of phages to treat chronic orthopaedic...
2.
Van Overfelt S, Duyvejonck H, Baeke F, De Rycke R, Merabishvili M, Vermeulen S, et al.
PLoS One
. 2024 Dec;
19(12):e0313774.
PMID: 39625917
To use phages in a personalized therapy and industrial applications, an accurate quantification is needed. The gold standard method, namely the culture-based double agar overlay (DAO) method, provides an accurate...
3.
Merabishvili M, Pirnay J
Lancet Infect Dis
. 2024 Nov;
24(12):1289-1291.
PMID: 39613342
No abstract available.
4.
Van Nieuwenhuyse B, Balcaen M, Chatzis O, Haenecour A, Derycke E, Detaille T, et al.
Front Cell Infect Microbiol
. 2024 Oct;
14:1354681.
PMID: 39355265
Maximal standard-of-care (SOC) management could not stop the life-threatening progression of a necrotizing fasciitis induced by Panton-Valentine Leukocidin-producing Methicillin-Resistant (MRSA) in a 12-year-old boy. Multi-route phage therapy was initiated along...
5.
Uyttebroek S, Dupont L, Wagemans J, Lavigne R, Merabishvili M, Coenye T, et al.
Int Forum Allergy Rhinol
. 2024 Aug;
15(1):73-76.
PMID: 39212056
Treatment of cystic fibrosis-related chronic rhinosinusitis should target sinonasal biofilms. NaHCO salts with/without xylitol have limited antibiofilm properties, whereas rhDNAse has not. Phage effectivity varies and depends on the phage...
6.
Alt V, Gessner A, Merabishvili M, Hitzenbichler F, Mannala G, Peterhoff D, et al.
Front Med (Lausanne)
. 2024 Jul;
11:1428432.
PMID: 39071087
Fracture-related infections can be challenging, particularly with concomitant severe bone defects and multi-resistant microorganisms. We present a case of a 42-year-old patient with a fracture-related infection following a war injury...
7.
Van Nieuwenhuyse B, Merabishvili M, Goeders N, Vanneste K, Bogaerts B, de Jode M, et al.
Viruses
. 2024 Jul;
16(7).
PMID: 39066209
Infections due to antimicrobial-resistant bacteria have become a major threat to global health. Some patients may carry resistant bacteria in their gut microbiota. Specific risk factors may trigger the conversion...
8.
Wang Z, De Soir S, Glorieux A, Merabishvili M, Knoop C, De Vos D, et al.
Int J Antimicrob Agents
. 2024 Jul;
64(3):107276.
PMID: 39009289
Objectives: Staphylococcus aureus and Pseudomonas aeruginosa co-infections in patients with cystic fibrosis (CF) are associated with disease severity. Their treatment is complicated by biofilm formation in the sticky mucus obstructing...
9.
Pirnay J, Djebara S, Steurs G, Griselain J, Cochez C, De Soir S, et al.
Nat Microbiol
. 2024 Jun;
9(6):1434-1453.
PMID: 38834776
In contrast to the many reports of successful real-world cases of personalized bacteriophage therapy (BT), randomized controlled trials of non-personalized bacteriophage products have not produced the expected results. Here we...
10.
De Soir S, Paree H, Kamarudin N, Wagemans J, Lavigne R, Braem A, et al.
Microbiol Spectr
. 2023 Dec;
12(1):e0321923.
PMID: 38084971
Biofilm-related infections are among the most difficult-to-treat infections in all fields of medicine due to their antibiotic tolerance and persistent character. In the field of orthopedics, these biofilms often lead...